Clinical Trial Result Information

Title of Study:
Open-label, randomised and multi-center study evaluating the efficacy and safety of an optimised background antiretroviral regimen (OB) compared to OB associated with enfuvirtide in previously treated HIV-1 infected patients in virological success after a 28-week induction treatment with enfuvirtide plus OB

Fast Facts:

Protocol number:	ML18242
Sponsor:	Roche SAS
Company division:	Pharmaceutical
Product name:	Fuzeon
Generic name:	enfuvirtide
Phase of development:	III
Therapeutic area, approved indication:	HIV infection
Date of report:	To be Published

Clinical study summary:
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Click here for the protocol registry listing of this trial.